Allarity Therapeutics, Inc.
ALLR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860657
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Allarity Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +6 vs. Q1 2026
- Shares held
- 1.28M
- +330.6K (+34.8%) vs. Q1 2026
- Total value
- $1.65M
- +$616.0K (+59.5%) vs. Q1 2026
- New holders
- 8
- 3 more added
- Sold out
- 2
- 3 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALLR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $1.65M |
| Q1 2026 | 14 | $1.04M |
| Q4 2025 | 16 | $1.40M |
| Q3 2025 | 11 | $1.63M |
| Q2 2025 | 10 | $197.0K |
| Q1 2025 | 9 | $86.5K |
| Q4 2024 | 6 | $122.3K |
| Q3 2024 | 4 | $46.2K |
| Q2 2024 | 9 | $107.8K |
| Q1 2024 | 4 | $11.7K |
| Q4 2023 | 4 | $31.8K |
| Q3 2023 | 7 | $515.6K |
| Q2 2023 | 4 | $33.3K |
| Q1 2023 | 6 | $4.05K |
| Q4 2022 | 10 | $42.0K |
| Q3 2022 | 10 | $181.0K |
| Q2 2022 | 10 | $304.0K |
| Q1 2022 | 10 | $694.0K |
| Q4 2021 | 3 | $270.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Allarity Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Danske Bank A/S | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 1 | $1 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 13 | $17 | 0.00% | +13 | New |
| Caitong International Asset Management Co., Ltd | 22 | $28 | 0.00% | +21+2,100.0% | Added |
| Tower Research Capital LLC (TRC) | 2,650 | $3.42K | 0.00% | +2,650 | New |
| Virtu Financial LLC | 15,322 | $20.0K | 0.00% | +15,322 | New |
| Susquehanna International Group, LLP | 17,221 | $22.2K | 0.00% | +17,221 | New |
| XTX Topco Ltd | 20,884 | $26.9K | 0.00% | −8,083−27.9% | Reduced |
| UBS Group AG | 26,589 | $34.3K | 0.00% | +3,431+14.8% | Added |
| Two Sigma Investments, LP | 27,492 | $35.5K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 36,021 | $46.5K | 0.00% | +36,021 | New |
| HRT Financial LP | 37,003 | $47.0K | 0.00% | +37,003 | New |
| Northern Trust Corp | 36,534 | $47.1K | 0.00% | −11,569−24.1% | Reduced |
| Vanguard Fiduciary Trust Co | 74,913 | $96.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 91,748 | $118.4K | 0.00% | +91,748 | New |
| Militia Capital Management LLC | 98,978 | $127.7K | 0.02% | +98,978 | New |
| State Street Corp | 137,600 | $177.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 154,867 | $199.8K | 0.00% | −35,526−18.7% | Reduced |
| Vanguard Capital Management LLC | 171,795 | $221.6K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 331,509 | $427.6K | 0.00% | +103,425+45.3% | Added |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,334−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −7,766−100.0% | Sold out |